AIM-quoted OptiBiotix Health (LON: OPTI) has floated its former subsidiary ProBiotix Health on the Aquis Stock Exchange, although it still retains a 44% stake. This enables the company to raise cash to finance its growth plans, while OptiBiotix can focus on its SlimBiome and SweetBiotix products.
One of the major reasons for spinning off ProBiotix at this time is that as an independent business it is eligible for EIS and VCT investment. OptiBiotix is not eligible. Joining Aquis is much cheaper than a flotation on AIM, particularly for such a small company.
ProBiotix is already generatin...
